There are 12,207 results relating to "Comprar en linda l"
Order by
|
Committee reports
Date published:
23 May 2018
Annual report 2017-18 - Equalities
Retrieved from <a href="https://www.imf.org/en/Publications/Policy-Papers/Issues/2017/05/12/pp041917gender-budgeting-in-g7-countries" target="_blank">https://www.imf.org/en/Publications/Policy-Papers/Issues/2017/05/12/pp041917gender-budgeting-in-g7-countries</a>
The Group recommended that the Scottish Gov...
Last updated:
4 March 2025
CPG on Deafness minutes for 5 Feb 2025
Via Zoom (an online video conferencing platform) Minutes – Present MSPs Convenor – Colin Beattie MSP (Scottish National Party) Roz McCall MSP (Conservative) Invited Guests Paula Spiers (NHS Scotland) Jenny Gray (PA for Colin Beattie) Janis McDonald, Emma Jones (the ALLIANCE) Individual Member Donald Richards Danny Sweeney Group Members Secretariat and Assistant: Hannah Tweed, Amy White (the ALLIANCE) John Whitfield, Jonathan Reid (Deafblind Scotland) Carla Marchbank (NESS) Nicholas Orpin (Hearing Link) Amanda McNamara (BATOD) Katie Edwards, Stephanie Rose (Police Scotland) Kirsten Abioye (Lothian Deaf Children’s Club/FLAAG) Matthew King, (Sorenson) Avril Hepner (BDA) Mark Ballard (NDCS) Lucy Vasiliou (AVUK) Jill Bradshaw (ATLA Scotland) Julie Ferguson (EIS) Adele Goman (Edinburgh Napier University) Rachel Mapson (QMU) Linda...
Last updated:
6 January 2025
Minute of meeting on 11 September 2024
Via Zoom (an online video conferencing platform) Minutes - Present MSPs Convenor – Colin Beattie MSP (Scottish National Party) Roz McCall MSP (Conservative) Karen Adam MSP (SNP) Annabelle Ewing MSP (SNP) Carol Mochan MSP (Labour) Invited Guests Hannah Tweed, Emma Jones (The ALLIANCE) Scott Steele, Jenny Gray (Colin Beattie MSP staff member) Tony Rednall, Gerald Ellison, Aileen McIntyre-Scottish Government Jenni Minto MSP/Minister for Public Health & Women’s Health Paula Spiers – NHS Scotland Deputy Chief Operating Officer Non-MSP Group Members Secretariat and Assistant: Janis McDonald, Amy White (The ALLIANCE) Tori Bishop-Rowe, Lucy Vasiliou (AVUK) Teresa Quail (BATOD) Philip Gerard (Deaf Action) Jacquie Winning (Forth Valley Sensory Centre) Avril Hepner, Rebecca Mansell (BDA Scotland and BDA) Brian Shannon Scottish Sensory Centre, Edinburgh University Christine Johnson – QMU Mike Henderson (Deafblind Scotland/FLAAG) Isabella Goldie, John Whitfield (Deafblind Scotland) Mark Ballard, Lois Drake (NDCS Scotland) Rachel Mapson (Queen Margaret University) Ruth McLeod (RNID) Linda...
SPICe briefings
Date published:
10 September 2021
Energy Policy - Subject Profile - Post-Brexit Framework
Retrieved from <a href="https://www.nortonrosefulbright.com/en/knowledge/publications/de27d8b1/the-impact-of-brexit-on-the-energy-sector" target="_blank">https://www.nortonrosefulbright.com/en/knowledge/publications/de27d8b1/the-impact-of-brexit-on-the-energy-sector</a> [accessed 2 August 2021]:
The UK’s ...
SPICe briefings
Date published:
5 July 2019
Seafood processing in Scotland: an industry profile - Introduction
Retrieved from <a href="https://publications.europa.eu/en/publication-detail/-/publication/a503b2a6-3b0c-11e9-8d04-01aa75ed71a1/language-en/format-PDF/source-97529671" target="_blank">https://publications.europa.eu/en/publication-detail/-/publication/a503b2a6-3b0c-11e9-8d04-01aa75ed71a1/language-en/format-PDF/source-97529671</a> [accessed 21 May 2019].
Last updated:
21 October 2025
WASPI CPG AGM MINS OCT25
Cross-Party Group on WASPI Scotland 9 Oct 2025 @ 6pm via zoom Minute Present MSPs Katy Clark Maggie Chapman Beatrice Wishart Invited guests Eileen Cawlet Joyce Stevenson Susan McKellar Non-MSP Group Members Wendy Millar C Houston C McMilllan K McDonald F Brown L Paterson M Eley R Dickson A Potter Apologies C Haughey I Fraser L Carmichael C Martinez Agenda item 1 AGM Business Chair Katy Clark (Re elected) Co Chair Maggie Chapman (Re elected) Joint Co Chair Beatrice Wishart 1 Secretariat Anne Potter (Re elected) Agenda item 2 State Pension Age Review - Ministers in Holyrood are currently dealing with their submission.
Last updated:
19 April 2023
NHS Borders Evidence Pack
Dec-22 111 Jan-23 64 ae decision to treat M Referral to Treatment (RTT) - % 90% patient to be seen and treated within 18 weeks of n ↑ Dec-22 67.9% Jan-23 88.4% al treated within 18 weeks of referral referral. P l Diagnostics (8 key tests) - Number Zero patients waiting longer than 6 weeks for 8 key a ↑ Dec-22 1202 Jan-23 1073 n waiting >6 weeks diagnostic tests oita CAMHS- % treated within 18 weeks of r ↓ 90% patients seen and treated within 18 weeks of referral Nov-22 31.3% Dec-22 30.8% e referral pO A&E 4 Hour Standard - Patients l 95% of patients seen, discharged or transferred within 4 a ↑ discharged or transferred within 4 Dec-22 63.5% Jan-23 64.7% hours u hours nn Delayed Discharges - Patients A ↑ Zero patients delayed in hospital for more than 72 hours Dec-22 33 Jan-23 45 delayed over 72 hours Psychological Therapies - % treated ↓ 90% patient treated within 18 weeks of referral Nov-22 84.1% Dec-22 81.3% within 18 weeks of referral Drug & Alcohol - Treated within 3 ↔ 90% patient treated within 3 weeks of referral Nov-22 100% Dec-22 100% weeks of referral ↑ Sickness Absence Rates Maintain overall sickness absence rates below 4% Dec-22 6.41% Jan-23 6.91% 14 Cancer Waiting Times (please note there is a 1-month lag time for data) Fig. 9 95% of suspicion of cancer cases seen within 62 Days Percentage Mean UCL LCL Standard % 120% 110% 100% 90% 80% 70% 60% 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 9 0 1 2 3 1 1 2 2 2 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p n n n n n n n n n n c c c c c u u u u u a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S D D D D D A A A A A N N N N N M M M M M M M M M Fig. 10 95% of cancer treatment patients treated within 31 Days Percentage Mean UCL LCL Standard % 105% 100% 95% 90% 85% 80% 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 9 0 1 2 3 1 1 2 2 2 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p n n n n n n n n n n c c c c c u u u u u a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S D D D D D A A A A A N N N N N M M M M M M M M M 15 Stage of Treatment- Outpatients Waiting Over 12 Weeks Stage of Treatment Target - Outpatients Waiting Over 12 Weeks 12wks Mean UCL LCL 8000 7000 6000 5000 4000 3000 2000 10000 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 9 0 1 2 3 1 1 2 2 2 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n -1000 c c c c c u u u u u a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N M M M M M M M M M Fig. 11 16 Stage of Treatment- Inpatients Waiting Over 12 Weeks Stage of Treatment Target - Inpatients Waiting Over 12 Weeks 12wks Mean UCL LCL 2500 2000 1500 1000 5000 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 9 0 1 2 3 1 1 2 2 2 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n c c c c c u u u u u a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N M M M M M M M M M Fig. 12 17 Patients Treated within the 12 weeks Treatment Time Guarantee Patients Treated within the 12 weeks Treatment Time Guarantee 12wks TTG Mean UCL LCL 250 200 150 100 500 -50 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 8 9 0 1 2 9 0 1 2 8 9 0 1 2 9 0 1 2 3 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n c c c c c u u u u u a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N M M M M M M M M M Fig. 13 18 18 Weeks Referral to Treatment Combined Pathway Performance 18 Weeks Percentage Referral to Treatment Combined Pathway Performance Percentage Mean UCL LCL Standard % 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 3 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n u u u u u c c c c c a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N M M M M M M M M M Fig. 14 19 Diagnostic Waits Diagnostics Waits over 6 Weeks Number over 6 weeks Mean UCL LCL 2000 1800 1600 1400 1200 1000 800 600 400 2000 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 8 9 0 1 2 9 0 1 2 3 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n u u u u u c c c c c a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N M M M M M M M M M Fig. 15 20 CAMHS Waiting Times- 18 Week Referral to Treatment 18 Week Referral to Treatment for CAMHS Percentage Mean UCL LCL Standard % 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 8 9 0 1 2 9 0 1 2 3 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p n n n n n n n n n n u u u u u c c c c c a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S D D D D D A A A A A N N N N N M M M M M M M M M Fig. 16 21 Psychological Therapies Waiting Times- 18 Week Referral to Treatment 18 Week Referral to Treatment for Pyschological Therapies Percentage Mean UCL LCL Standard % 110% 90% 70% 50% 30% 10% -10% 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 9 0 1 2 3 1 1 2 2 2 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p n n n n n n n n n n c c c c c u u u u u a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S D D D D D A A A A A N N N N N M M M M M M M M M Fig. 17 22 Delayed Discharges Fig. 18 23 Fig. 19 DDs at Census Delayed over 72 Hours DDs over 72 hours (3 days) Mean UCL LCL 70 60 50 40 30 20 100 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 3 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n u u u u u c c c c c a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N M M M M M M M M M Fig. 20 Standard Delayed Bed Days Standard Delayed Bed Days Mean UCL LCL 2000 1500 1000 5000 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 8 9 0 1 2 9 0 1 2 3 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n u u u u u c c c c c a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N M M M M M M M M M 24 Drugs & Alcohol 3 Week Drugs and Alcohol Referral to Treatment Percentage Mean UCL LCL Standard % 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 9 0 1 2 1 1 2 2 2 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p n n n n n n n n n c c c c c u u u u u a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a e e e e e e e e e u u u u u J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S D D D D D A A A A A N N N N N M M M M M M M M M Fig. 21 25 Number of Alcohol Brief Interventions Delivered Trajectory Tolerance 2018/19 2020/21 2019/20 2020/21 2021/22 2022/23 2500 2000 1500 1000 5000 Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Fig. 22 26 Sickness Absence Sickness Absence Percentage below 4% 8% Percentage Mean UCL LCL Standard % 6% 4% 2% 0% … … … … … … … … … - - - - - - - - - 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 8 9 0 1 2 9 0 1 2 3 r r r r y y y y y 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 a a a a a a a a a - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r c c c c c v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n M M M M c c c c c u u u u u M M M M M p p p p p e e e e e o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N Fig. 23 Covid Absence Percentage Percentage Mean UCL LCL 6% 5% 4% 3% 2% 1% 0% -1% 0 1 2 0 1 2 0 1 2 0 1 2 0 1 1 2 2 3 0 1 2 0 1 2 0 1 2 1 2 0 1 2 1 2 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l t t t r r r r r c c c y y y v v v g g g p b p b p b n n n n n n u u u c c c a a p p p e e e a a a o o o u u u a a a e e e e e e u u u J J J J J J J J J O O O A A A S F S F S F D D D A A A N N N M M M M M Fig. 24 27 Smoking Quits (Please Note: All figures are cumulative.
SPICe briefings
Date published:
20 August 2021
Equalities and Human Rights: Subject Profile - International human rights framework
Retrieved from <a href="https://www.equalityhumanrights.com/en/what-are-human-rights/what-universal-declaration-human-rights" target="_blank">https://www.equalityhumanrights.com/en/what-are-human-rights/what-universal-declaration-human-rights</a> [accessed 11 May 2021] It sets out that basic rights and fu...
SPICe briefings
Date published:
21 May 2020
The European Union's response to COVID-19 - The EU response - a summary
Retrieved from <a href="https://www.consilium.europa.eu/en/press/press-releases/2020/03/10/statement-by-the-president-of-the-european-council-following-the-video-conference-on-covid-19/" target="_blank">https://www.consilium.europa.eu/en/press/press-releases/2020/03/10/statement-by-the-president-of-the-european...
SPICe briefings
Date published:
15 March 2024
Public participation in the Scottish Parliament: Understanding the core principles of deliberative democracy and creating a framework for measuring impact - Annex 2 - Ladder of community participation
Annex 2 - Ladder of community participation
Figure 3: Roberts et al’s Ladder of community participation(Roberts et al. 2023)1Roberts, J.J., Gooding, L., Ford, R., & Dickie, J. (2023).
